Why Are Clinical Trials Not Typically a Care Option?

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?What are the enablers or requirements to incorporate clinical research into care options for the patient?How to pave a path for possibilityUpdate on data to support how trials can be a care option This discussion was held at the Clinical Research as a Care Option (CRAACO) meeting held April 11, 2018 in Cambridge, MA. The 2019 CRAACO meeting will take place April 29-30 in Raleigh-Durham, NC. Find out more here.